Form 4: Roivant Sciences President & COO Eric Venker Executes Stock Option and Sells Shares
SEC Form 4 Filing
Eric Venker, President & COO of Roivant Sciences, exercised stock options and sold 100,000 common shares at a weighted average price of $10.65 on February 20, 2025.
Summary
- On February 20, 2025, Eric Venker, the President & COO of Roivant Sciences Ltd., exercised stock options to acquire 100,000 common shares at a price of $3.85 per share.
- Simultaneously, Venker sold 100,000 common shares at a weighted average price of $10.65.
- Following these transactions, Venker directly owns 885,924 common shares.
- The sale was executed to cover tax obligations related to the vesting and settlement of previously granted Restricted Stock Units (RSUs).
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing insider transactions, which carries a neutral sentiment.
Industry Context
This filing reflects routine insider transactions and is typical for executives holding stock options and RSUs in publicly traded companies. The sale of shares often occurs to cover tax obligations associated with vesting equity.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it involves the sale of shares by an executive, which could slightly increase the available float.
Key Dates
| Date | Description |
|---|---|
| 04/20/2022 | Vesting commencement date of stock options. |
| 02/20/2025 | Date of stock option exercise and sale of common shares. |
| 02/24/2025 | Date of signature on the SEC Form 4 filing. |
| 04/19/2032 | Expiration date of the stock options. |
Keywords
Roivant Sciences, Eric Venker, Stock Options, Common Shares, SEC Form 4, Insider Trading, RSUs, Securities Exchange Act
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.